wu qing yi - Net Worth and Insider Trading
wu qing yi Net Worth
The estimated net worth of wu qing yi is at least $63 Million dollars as of 2025-07-08. wu qing yi is the senior management of Dizal (Jiangsu) Pharmaceutical Co Ltd and owns about 974,229 shares of Dizal (Jiangsu) Pharmaceutical Co Ltd (SHSE:688192) stock worth over $63 Million. Details can be seen in wu qing yi's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that wu qing yi has not made any transactions after 2025-07-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of wu qing yi
wu qing yi Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, wu qing yi owns 1 companies in total, including Dizal (Jiangsu) Pharmaceutical Co Ltd (SHSE:688192) .
Click here to see the complete history of wu qing yi’s form 4 insider trades.
Insider Ownership Summary of wu qing yi
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
SHSE:688192 | Dizal (Jiangsu) Pharmaceutical Co Ltd | 2025-07-04 | senior management |
wu qing yi Latest Holdings Summary
wu qing yi currently owns a total of 1 stock. wu qing yi owns 974,229 shares of Dizal (Jiangsu) Pharmaceutical Co Ltd (SHSE:688192) as of July 4, 2025, with a value of $63 Million.
Latest Holdings of wu qing yi
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SHSE:688192 | Dizal (Jiangsu) Pharmaceutical Co Ltd | 2025-07-04 | 974,229 | 64.86 | 63,188,493 |
Holding Weightings of wu qing yi
wu qing yi Form 4 Trading Tracker
According to the SEC Form 4 filings, wu qing yi has made a total of 4 transactions in Dizal (Jiangsu) Pharmaceutical Co Ltd (SHSE:688192) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in Dizal (Jiangsu) Pharmaceutical Co Ltd is the sale of 80,024 shares on July 4, 2025, which brought wu qing yi around $5 Million.
Insider Trading History of wu qing yi
- 1
wu qing yi Trading Performance
GuruFocus tracks the stock performance after each of wu qing yi's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by wu qing yi is -7.52%. GuruFocus also compares wu qing yi's trading performance to market benchmark return within the same time period. The performance of stocks bought by wu qing yi within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how wu qing yi's insider trading performs compared to the benchmark.
wu qing yi Ownership Network
Ownership Network List of wu qing yi
Ownership Network Relation of wu qing yi

wu qing yi Owned Company Details
What does Dizal (Jiangsu) Pharmaceutical Co Ltd do?
Who are the key executives at Dizal (Jiangsu) Pharmaceutical Co Ltd?
wu qing yi is the senior management of Dizal (Jiangsu) Pharmaceutical Co Ltd. Other key executives at Dizal (Jiangsu) Pharmaceutical Co Ltd include senior management zhang , Directors & senior managers & core technical personn , and Core technical personnel Qiao Wei Jun .
Dizal (Jiangsu) Pharmaceutical Co Ltd (SHSE:688192) Insider Trades Summary
Over the past 18 months, wu qing yi made 4 insider transaction in Dizal (Jiangsu) Pharmaceutical Co Ltd (SHSE:688192) with a net sale of 94,188. Other recent insider transactions involving Dizal (Jiangsu) Pharmaceutical Co Ltd (SHSE:688192) include a net purchase of 6,433,544 shares made by , a net sale of 1,800 shares made by zhang , and a net purchase of 160,972 shares made by .
In summary, during the past 3 months, insiders sold 779,244 shares of Dizal (Jiangsu) Pharmaceutical Co Ltd (SHSE:688192) in total and bought 0 shares, with a net sale of 779,244 shares. During the past 18 months, 779,244 shares of Dizal (Jiangsu) Pharmaceutical Co Ltd (SHSE:688192) were sold and 7,299,188 shares were bought by its insiders, resulting in a net purchase of 6,519,944 shares.
Dizal (Jiangsu) Pharmaceutical Co Ltd (SHSE:688192)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dizal (Jiangsu) Pharmaceutical Co Ltd Insider Transactions
wu qing yi Mailing Address
Above is the net worth, insider trading, and ownership report for wu qing yi. Currently GuruFocus does not have mailing address information for wu qing yi.